ONE WORLD PRODUCTS INC - OWPC STOCK NEWS

One World Products (OTC: OWPC) has appointed Isiah Thomas as Executive Chairman while he retains his role as CEO. The company continues to expand in the industrial hemp market, focusing on bioplastic production and supplier diversity programs with major corporations. Recently, One World was included in the Stellantis-National Business League Black Supplier Development Program, which will involve supplying hemp-based bioplastic solutions to Stellantis N.V. This appointment and new partnerships highlight the company's commitment to sustainable practices and environmental, social, and governance (ESG) standards.

One World Pharma changes its name to One World Products: Sustainable Hemp and Cannabis Solutions, effective December 1, 2021. This rebranding reflects its expanding role in the cannabis and hemp industries and aligns with its commitment to ESG standards. The company is recognized as a significant player in developing hemp-based bioplastics through its collaboration with Stellantis. Shareholders will not need to take action regarding the name change. One World Products remains the largest Black-controlled cannabis and hemp producer in Colombia, emphasizing high-quality industrial applications.

One World Universe (OTC: OWUV) has announced a plan to buy back around 5 million shares to ease shareholder dilution concerns. CFO Caren Currier stated that the shares will be deposited back into the treasury and potentially used as leverage for future acquisitions. The company is also looking to enter the Metaverse space and plans to announce two additional acquisitions by year-end. Management has engaged with various stakeholders, including entrepreneurs and large shareholders, to explore business opportunities aimed at enhancing shareholder value.

One World Pharma announces its participation in the National Black Supplier Development Program, aimed at enhancing collaboration with Black businesses for contracting opportunities. This initiative, in partnership with Stellantis and the National Business League, seeks to capitalize on the expanding hemp market, expected to reach $36 billion globally by 2026. The company aims to provide significant amounts of hemp fiber for bioplastics manufacturing, projecting a need for 300,000 metric tons by 2025. One World Pharma emphasizes its commitment to environmental, social, and governance (ESG) principles.

One World Pharma (OTC: OWPC) has begun construction on a vertically integrated extraction facility in Colombia, becoming one of the first companies in the country with both licenses and the capability to produce high-quality CBD and THC oils. The facility, designed in partnership with United Sciences, will process cannabis flower and aims for operational status within six months, targeting EU GMP certification by mid-2022. This initiative signifies a major step in the company’s growth, enhancing its environmental responsibility and compliance with ESG standards.

One World Pharma (OTC: OWPC) announced the appointment of Vahé Gabriel as its Chief Operating Officer and Chief Financial Officer. Gabriel brings over 20 years of leadership experience in finance and operations, with a strong focus on optimizing organizational performance. His prior roles include CEO of Atthis LLC and President & COO of CGL Companies. Gabriel expressed enthusiasm for joining One World, emphasizing the company’s strategic position in the cannabis and hemp market, particularly with its substantial Colombian land holdings. The company aims to meet growing product demand while adhering to ESG standards.

One World Pharma (OTC: OWPC) has retained CORE IR for investor relations and public relations services to enhance market awareness. The partnership aims to communicate the company's growth strategies to both institutional and retail investors. CEO Isiah Thomas highlighted the importance of conveying One World's unique story as it continues to grow. CORE IR specializes in strategic communications for small to mid-sized companies. One World Pharma is a licensed cannabis and hemp producer, with operations in Colombia, focusing on high-quality products and maintaining strong ESG standards.

One World Pharma Inc. (OTCQB: OWPC) has announced a significant milestone by completing its first sale of cannabis plantlets in Colombia. The plantlets, which can be transplanted immediately, illustrate the company's secured licenses and the desirability of its superior genetic cannabis strains among growers. Current production capacity stands at 9,000 cuttings per cycle, with plans to double this to 18,000 by year-end, indicating strong potential for revenue growth. This development follows other positive news, such as high-level endorsements and regulatory approvals that further enhance market opportunities.

On April 26, 2021, One World Pharma (OTC: OWPC) announced its first sales of cannabis cuttings following approval from Instituto Colombiano Agropecuario (ICA). The company can now sell genetically superior plantlets, enhancing customer options by reducing germination risks. Currently, OWP has a production capacity of 9,000 cuttings per 20-day cycle, with plans to expand to 18,000 by year-end. This initiative complements existing revenue streams from seed and oil sales and strengthens OWP’s market position in cannabis genetics.